Literature DB >> 19190810

Heparin-induced thrombocytopenia: what clinicians need to know.

Beng H Chong1, Arend Isaacs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190810

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

Review 1.  Update on heparin: what do we need to know?

Authors:  Daniel S Weitz; Jeffrey I Weitz
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

Review 2.  An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Lucia Ciucciarelli; Anna Maria Cameli; Gentian Denas; Mario Milco D'Elios; Vittorio Pengo; Lorenzo Emmi; Domenico Prisco
Journal:  ScientificWorldJournal       Date:  2014-10-14

3.  Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia.

Authors:  José Perdomo; Halina H L Leung; Zohra Ahmadi; Feng Yan; James J H Chong; Freda H Passam; Beng H Chong
Journal:  Nat Commun       Date:  2019-03-21       Impact factor: 14.919

4.  Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia.

Authors:  Halina H L Leung; Jose Perdomo; Zohra Ahmadi; Feng Yan; Steven E McKenzie; Beng H Chong
Journal:  Blood Adv       Date:  2021-12-14

5.  NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia.

Authors:  Halina H L Leung; Jose Perdomo; Zohra Ahmadi; Shiying S Zheng; Fairooj N Rashid; Anoop Enjeti; Stephen B Ting; James J H Chong; Beng H Chong
Journal:  Nat Commun       Date:  2022-09-05       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.